Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Makaleler > Tam Makale · 2019
Yazarlar: Muriel Elhai, Marouane Boubaya, Oliver Distler, Vanessa Smith, Marco Matucci-Cerinic, Juan Jose Alegre Sancho, Marie-Elise Truchetet, Yolanda Braun-Moscovici, Florenzo Iannone, Pavel I. Novikov, Alain Lescoat, Elise Siegert, Ivan Castellvi, Paolo Airo, Serena Vettori, Ellen De Langhe, Eric Hachulla, Anne Erler, Lidia Ananieva, Martin Krusche, F. J. Lopez-Longo, Joerg H. W. Distler, Nicolas Hunzelmann, Anna-Maria Hoffmann-Vold, Valeria Riccieri, Vivien M. Hsu, Maria R. Pozzi, Codrina Ancuta, Edoardo Rosato, Carina Mihai, Masataka Kuwana, Lesley Ann Saketkoo, Carlo Chizzolini, Roger Hesselstrand, Susanne Ullman, Sule Yavuz, Simona Rednic, Cristian Caimmi, Coralie Bloch-Queyrat, Yannick Allanore, Serena Guiducci, Ulrich A. Walker, Diego Kyburz, Giovanni Lapadula, Britta Maurer, Suzana Jordan, Rucsandra Dobrota, Radim Becvar, Stanislaw Sierakowsky, Otylia Kowal Bielecka, Alberto Sulli, Maurizio Cutolo, Giovanna Cuomo, Ileana Nicoara, Andre Kahan, Panayiotis G. Vlachoyiannopoulos, Carlo Maurizio Montecucco, Roberto Caporali, Jiri Stork, Murat Inanc, Patricia E. Carreira, Srdan Novak, Laszlo Czirjak, Cecilia Varju, Eugene J. Kucharz, Anna Kotulska, Magdalena Kopec-Medrek, Malgorzata Widuchowska, Franco Cozzi, Blaz Rozman, Carmel Mallia, Bernard Coleiro, Armando Gabrielli, Dominique Farge, Chen Wu, Zora Marjanovic, Helene Faivre, Darin Hij, Roza Dhamadi, Frank Wollheim, Agneta Scheja, Dirk M. Wuttge, Kristofer Andreasson, Duska Martinovic, Alexandra Balbir-Gurman, F. Trotta, Andrea Lo Monaco, Raffaele Pellerito, Ospedale Mauriziano, Paola Caramaschi, Jadranka Morovic-Vergles, Carol Black, Christopher Denton, Nemanja Damjanov, Jorg Henes, Vera Ortiz Santamaria, Stefan Heitmann, Dorota Krasowska, Matthias Matthias, Paul Hasler, Fahrettin OKSEL, Figen YARGUCU ZİHNİ
ANNALS OF THE RHEUMATIC DISEASES, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2019, cilt 78, ss 979-987
DOI: 10.1136/annrheumdis-2018-214816
Özet
Objective To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical practice.